EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Efficacy of Adjunct Olanzapine Treatment in Adolescents With Anorexia Nervosa: A Comparison of Two Patient Cohorts

Helene Krauss iD, Michael Zeiler iD, Dunja Mairhofer, Julia Klang iD, Julia Schwarzenberg, Michaela Mitterer, Gudrun Wagner iD, Maria Glüder, Karin Egberts iD, Manfred Gerlach, Andreas Karwautz iD

European Eating Disorders Review · 2025

DOI: 10.1002/erv.70009 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Eating Disorders Review, 2025. Verfasst von Helene Krauss und 10 weiteren Autor:innen. Beteiligte Einrichtung: Eating Disorders Unit, Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Anorexia Nervosa, Antipsychotic Agents, Weight Gain, Benzodiazepines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesinstitut für Arzneimittel und Medizinprodukte, German Federal Ministry of Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anorexia nervosa (AN) is a severe psychiatric disorder with high mortality, requiring innovative treatment strategies. Olanzapine (OLZ), an atypical antipsychotic, has demonstrated efficacy in promoting weight gain and reducing psychopathological symptoms in adults with AN. However, its efficacy and safety in adolescents remain insufficiently explored.

Objective

This study assessed the impact of adjunctive OLZ in adolescents with AN during inpatient care, focussing on weight gain, eating disorder pathology, and metabolic safety.

Methods

A naturalistic, prospective study compared two groups of adolescent inpatients with AN ( n = 47 each), one receiving standard multidisciplinary care plus OLZ and one receiving standard care alone (Non‐OLZ). Weekly weight gain as well as admission‐to‐discharge changes in body‐mass‐index, eating disorder symptoms, and metabolic markers were compared between the two cohorts.

Results

The OLZ group (∅ 9 mg/day) achieved greater weekly weight gain (0.898 vs. 0.677 kg, p = 0.004) compared to the Non‐OLZ group. Both groups showed similar reductions in eating disorder pathology; however, improvements in body dissatisfaction were larger in the Non‐OLZ group. Administration of OLZ was associated with significant prolactin level increases.

Conclusions

OLZ is a promising adjunctive treatment for adolescents in terms of supporting weight gain during inpatient care. However, psychological effects and possible metabolic risks warrant further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anorexia NervosaAntipsychotic AgentsWeight GainBenzodiazepinesHumansOlanzapineAdolescentFemaleProspective StudiesTreatment OutcomeMaleBody Mass Index

Stichwörter der Autor:innen

adolescentsanorexia nervosaeating disordersolanzapinepsychopharmacology

Substanzen

OlanzapineAntipsychotic AgentsBenzodiazepines

Autor:innen und Institutionen

  • Eating Disorders Unit, Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.
  • Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Centre for Mental Health, University Hospital of Wuerzburg, Wuerzburg, Germany.

ORCID-Profile: Helene Krauss, Michael Zeiler, Julia Klang, Gudrun Wagner, Karin Egberts, Andreas Karwautz

Förderung

  • Bundesinstitut für Arzneimittel und Medizinprodukte
  • German Federal Ministry of Education and Research

Zitieren

APA

Krauss, H., Zeiler, M., Mairhofer, D., Klang, J., Schwarzenberg, J., Mitterer, M., Wagner, G., Glüder, M., Egberts, K., Gerlach, M., & Karwautz, A. (2025). Efficacy of Adjunct Olanzapine Treatment in Adolescents With Anorexia Nervosa: A Comparison of Two Patient Cohorts. European Eating Disorders Review. https://doi.org/10.1002/erv.70009

Vancouver

Krauss H, Zeiler M, Mairhofer D, Klang J, Schwarzenberg J, Mitterer M, et al. Efficacy of Adjunct Olanzapine Treatment in Adolescents With Anorexia Nervosa: A Comparison of Two Patient Cohorts. European Eating Disorders Review. 2025. doi:10.1002/erv.70009

BibTeX
@article{Krauss2025,
  author = {Krauss, Helene and Zeiler, Michael and Mairhofer, Dunja and Klang, Julia and Schwarzenberg, Julia and Mitterer, Michaela and Wagner, Gudrun and Glüder, Maria and Egberts, Karin and Gerlach, Manfred and Karwautz, Andreas},
  title = {Efficacy of Adjunct Olanzapine Treatment in Adolescents With Anorexia Nervosa: A Comparison of Two Patient Cohorts},
  journal = {European Eating Disorders Review},
  year = {2025},
  doi = {10.1002/erv.70009}
}
Kostenlos starten →